FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study
Azenta(AZTA) Prnewswire·2024-07-22 20:05Azenta will provide proteomics technology profiling on up to 20,000 individuals.BURLINGTON, Mass., July 22, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland. The FinnGen project is a pioneering endeavor that has collected and is currently analyzing genomic and health data from a cohort of 500,000 Finnish biobank participants.In collaboration with the University of ...